Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (91-100 of 349) with videos related to

Pageof 35
Sort By:
BJU International|March 6, 2010
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenariansPhillip M Pierorazio, Elizabeth Humphreys, Patrick C Walsh, et al.
Urology|October 18, 2002
Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screeningLars Ellison, Carol D Cheli, Steven Bright, et al.
Human Pathology|August 31, 2002
Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?Michael P Viglione, Stephen Potter, Alan W Partin, et al.
BJU International|April 8, 2018
Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefitMohit Gupta, Hiten D Patel, Zeyad R Schwen, et al.
The Journal of Urology|September 6, 2006
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortalityStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
The Journal of Urology|March 20, 2012
Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancerJeffrey K Mullins, Misop Han, Phillip M Pierorazio, et al.
Urology|July 3, 2003
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Masood A Khan, Misop Han, Alan W Partin, et al.
BJU International|June 26, 2004
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons, Michael K Brawer, Carol D Cheli, et al.
The Prostate|July 13, 2010
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomyRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
Urology|September 8, 2004
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progressionHakan Aydin, Toyonori Tsuzuki, David Hernandez, et al.
Pageof 35

Showing results (91-100 of 349) with videos related to

Sort By:
Pageof 35
BJU International|March 6, 2010
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenariansPhillip M Pierorazio, Elizabeth Humphreys, Patrick C Walsh, et al.
Urology|October 18, 2002
Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screeningLars Ellison, Carol D Cheli, Steven Bright, et al.
Human Pathology|August 31, 2002
Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?Michael P Viglione, Stephen Potter, Alan W Partin, et al.
BJU International|April 8, 2018
Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefitMohit Gupta, Hiten D Patel, Zeyad R Schwen, et al.
The Journal of Urology|September 6, 2006
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortalityStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
The Journal of Urology|March 20, 2012
Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancerJeffrey K Mullins, Misop Han, Phillip M Pierorazio, et al.
Urology|July 3, 2003
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Masood A Khan, Misop Han, Alan W Partin, et al.
BJU International|June 26, 2004
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSAJ Kellogg Parsons, Michael K Brawer, Carol D Cheli, et al.
The Prostate|July 13, 2010
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomyRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
Urology|September 8, 2004
Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progressionHakan Aydin, Toyonori Tsuzuki, David Hernandez, et al.
Pageof 35